BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Kinetin identified as a potential new SARS-CoV-2 antiviral compound
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Infection
Kinetin identified as a potential new SARS-CoV-2 antiviral compound
Feb. 6, 2023
No Comments
Researchers from Fundacao Oswaldo Cruz (Fiocruz) have evaluated kinetin (MB-905) as an antiviral against SARS-CoV-2.
BioWorld Science
Infection
Coronavirus